SHI Linyong, YU Xuecong, DU Qianru, WANG Yaoyong. Research progress in immune disorders and glucocorticoid therapy in severe viral pneumonia[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 139-142, 148. DOI: 10.7619/jcmp.20245300
Citation: SHI Linyong, YU Xuecong, DU Qianru, WANG Yaoyong. Research progress in immune disorders and glucocorticoid therapy in severe viral pneumonia[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 139-142, 148. DOI: 10.7619/jcmp.20245300

Research progress in immune disorders and glucocorticoid therapy in severe viral pneumonia

  • Immune dysfunction plays a pivotal role in the pathogenesis and progression of severe viral pneumonia. Both hyperactivated immune responses and immunosuppressive states may adversely affect clinical outcomes. Glucocorticoids, widely utilized as immunomodulatory agents, hold significant therapeutic value in managing this condition. Elucidating the intricate mechanisms underlying immune dysregulation in these patients, accurately assessing individualized immune profiles, and optimizing glucocorticoid regimens alongside other immunomodulatory interventions are critical to improving clinical success rates. This review synthesized current progress in research on immune disorders and glucocorticoid therapy in severe viral pneumonia, providing theoretical foundations for clinical practice to enhance patient prognosis.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return